Finn Partners has acquired Medical & Health Consulting, Paris-headquartered firm that works for biopharma, technology and medical devices outfits, to bolster its position in Europe.
Mina Volovitch, senior partner, Health, FINN Paris; Marie-Hélène Coste, MHC founding director and senior partner, Health, FINN Paris; and Gil Bashe, managing partner, FINN Global Health.
Marie-Helene Coste, MHC founding director, will take on the role of senior director, health for Finn Europe. She will report to Chantal Bowman-Boyles, managing partner of Europe and Gil Bashe, managing partner of global health.
"MHC is one of France's most highly regarded medical device, life science and professional association consultancies and recognizes that when health professionals collaborate, the beneficiaries are the patients they seek to serve," Bashe told O'Dwyer's. "They are the ideal match for Finn in France."
Peter Finn noted that Coste and her firm "are renowned sector leaders and their work extends beyond France and Europe."
He called MHC a "perfect complement" to his firm's September acquisition of high-science healthcare firm Lazar Partners, a 22-member New York firm.
Finn Partners is O'Dwyer's No. 6-ranked healthcare company with $21.2M in fees in 2018.